# Causeway Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/causeway-therapeutics

- Industry: Biotechnology
- Headquarters: Glasgow, UK
- Website: www.causewaytherapeutics.com
- Total disclosed funding: $1.3M
- Latest round: Seed (Jul 20, 2017)
- Investors on record: 2

## About

Causeway Therapeutics Ltd is a biotechnology company focused on developing innovative gene therapies that target genetic disorders, aiming to provide effective solutions for rare diseases with limited treatment options.Founded in 2015 and headquartered in Glasgow, UK, Causeway Therapeutics specializes in genetic disorder therapies. The company successfully raised GBP 1 million in Seed funding on July 20, 2017, co-led by Mediqventures and Scottish Enterprise, valuing it at GBP 2.94 million post-money. The company's CEO is Derek Gilchrist.Causeway Therapeutics specializes in developing innovative therapies to address unmet medical needs in genetic disorders. Their flagship offerings include gene therapy solutions utilizing advanced biotechnological methods to specifically target genetic mutations, providing potential cures for conditions with limited treatment options. Their products serve a diverse client base, including healthcare providers, research institutions, and patients, primarily marketed in North America and Europe.Causeway Therapeutics operates on a revenue model comprising direct-to-consumer sales and partnerships with healthcare institutions and pharmaceutical companies. Their transactions involve structured agreements that include licensing fees, milestone payments, and potential royalties from product sales. The company’s pricing strategy reflects the premium nature of its gene therapy products, while partnerships with hospitals and clinics enhance access and distribution.Causeway Therapeutics plans to expand its product line with new gene therapies designed to address additional genetic disorders. The company targets expansion into European and North American markets by 2024, leveraging its recent Seed funding of GBP 1 million to support these initiatives. The funding will assist in R&D efforts for new product launches and bolster marketing strategies to enhance market presence.

## Funding rounds

- Seed, Jul 20, 2017, $1.3M — Mediqventures, Scottish Enterprise

## Investors

- Mediqventures (https://capitalatlas.ai/funds/mediqventures) — Seed
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Seed